Pfizer Could Year-End Target Hit on 2-to-1 Trial Payoff
Pfizer stock climbs as analysts weigh a pivotal prostate cancer trial. A Guggenheim bull case sees a $36 target by ye...
Find out Which Altcoins Have Active Contributors to gauge community health and collaboration across developers and teams.
26,356 articlesPfizer stock climbs as analysts weigh a pivotal prostate cancer trial. A Guggenheim bull case sees a $36 target by ye...
Three top clean energy ETFs have surged more than 50% over the past year, offering divergent paths to the green trans...
A mid-week move in Constellation Energy shares sparked questions about momentum and fundamentals. This piece breaks d...
A bold shift in AI strategy rewrite the investment thesis around Alphabet. OpenAI exits the AI video space, creating ...
A popular long-duration corporate bond ETF is attracting fresh attention as rate bets shift. Investors are weighing t...
Ripple announces a security collaboration with Crypto ISAC to share North Korea-linked threat intel, aiming to streng...
Joby Aviation stock today? Investors are asking why the shares moved. This article breaks down the catalysts, what’s ...
A midstream-focused energy ETF aims to deliver reliable income through toll-road style fees rather than volatile comm...
Caris Life Sciences blends lab testing with AI-driven insights to tackle oncology challenges. This piece breaks down ...
As 2026 unfolds, Main Street stocks like MAIN reveal how middle-market finance navigates rising rates and credit shif...
A lesser-known chip stock is catching the AI wave’s spotlight. This article breaks down why it’s rallying, what fuels...
Bank Of America boosts its Affirm Holdings target to $88 after a solid quarter, framing May 12 investor day as a cata...